Ataxin-3 interactors that show an increase or decrease larger than 10% in their percentage of interfacing sites with the expanded ataxin-3 form compared with the WT form are likely relevant in SCA3/MJD. Here, ATXN3 is linked to Spinocerebellar ataxia type 3.